corporate governance

Law firm Halper Sadeh investigates potential fiduciary duty breaches by Eagle Pharmaceuticals executives and directors, inviting shareholders to discuss legal options.

VersaBank shareholders overwhelmingly reelected all directors (98.55%-99.81% approval) and approved Ernst & Young as auditors at April 8 annual meeting. By-law amendment enables separate President and CEO roles.

Integer Holdings names veteran medtech executive Donald Spence as new independent board chair following Pamela Bailey's planned retirement in May 2026.

Klépierre's board names Stanley Shashoua chairman after David Simon's 14-year tenure ends with his death. Emmanuel Cronier joins as board member.

Klépierre appoints Stanley Shashoua as new Supervisory Board Chairman following David Simon's 14-year tenure, with stable board composition preserved.

SPIE SA reports €10.4 billion revenue and €793 million EBITA for 2025, filing comprehensive annual documentation with French regulator.

Ontex schedules May 2026 shareholder meeting as major investor Niessen/Mont Cervin stake falls below 3% threshold.

Vallant Financial Inc., a $3.98 billion Georgia-based bank holding company, begins trading on OTCQX under ticker $VLNT with Piper Sandler as corporate broker.

Global Net Lease directors Sue Perrotty and Edward Rendell retiring after 2026 annual meeting. Board shrinking to eight members.

Telix Pharmaceuticals appoints experienced life sciences executive David Gill as Non-Executive Director, with planned succession to Chair role, bringing 35+ years of CFO and commercial expertise.

Swedish fertility tech firm Vitrolife AB will hold its annual meeting May 5, 2026, to vote on board elections, dividends, share buybacks, and long-term incentive plans.

Klépierre files 2025 Universal Registration Document with French regulator ahead of May 7 shareholder meeting. Former Chairman David Simon has passed.

Klépierre files 2025 Universal Registration Document with French AMF on April 1, 2026. Portfolio valued at €21.2 billion as of year-end 2025.

AB Volvo completes conversion of 745,007 Series A shares to Series B shares, reducing total voting power to 600.7 million votes as of March 31, 2026.

Valeo shareholders will meet May 21, 2026 in Paris to approve 2025 results, €0.44 dividend, board changes, and executive compensation policies.

Valeo announces May 2026 shareholder meeting with €0.44 per share dividend proposal, board renewals, and governance updates.

Frontline plc announces resignations of two board directors Richard C. Prince and Ørjan Svanevik. Company files 2025 annual report.

Frontline plc files 2025 annual report; board members Richard C. Prince and Ørjan Svanevik resign. Orderly leadership transition in major tanker shipping operator.

Umicore released 2025 Annual Report ahead of April shareholder meeting, highlighting 31% emissions reduction and renewable energy milestone amid board restructuring.

UCB SA schedules April 30, 2026 shareholder meeting to approve €1.45 dividend, renew CEO mandate, and authorize 10% share buyback program.